The Dexcom G7 was impacted the most by this malfunction. Over 1.9 million of these blood glucose receivers have been cited by the FDA as being affected by the issue.

What's new The Dexcom G7 is known as a CGM, or constant glucose monitor. It sends readings every five minutes from a tiny sensor under your skin to your smartphone or a receiver via Bluetooth.

The GameSir G7 Pro is a powerful controller featuring responsive controls and mappable buttons, along with swappable D-pads ...

The Dexcom G7’s Direct to Apple Watch feature will allow you to receive real-time blood glucose readings and alerts on the wrist without your phone.

The FDA has approved Dexcom's G7 wearable for glucose monitoring for people with all types of diabetes, and the company expects it hit pharmacy shelves in 2023.

7 Dexcom, data on file, 2024. * Individuals who do not have a compatible smart device are eligible for a free G7 Receiver and should contact Dexcom Customer Service at 1-844-832-1810.

President Trump left the G7 summit early and abruptly to deal with the conflict between Israel and Iran.

The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.

The FDA’s nod for the G7 system comes several months after Dexcom secured CE mark clearance and began rolling out the sensor across Europe.

Dexcom, Inc., the global leader in real-time continuous glucose monitoring for people with diabetes, announced today its next-generation Dexcom G7 CGM System will be covered for Medicare ...